Eunuchism clinical trials
The registry lists 53 studies for Eunuchism across more than 10 countries. 17 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-14.
Status
- Completed
- 27
- Recruiting
- 11
- Not yet recruiting
- 5
- Status unknown
- 3
- Terminated
- 2
- Active, not recruiting
- 2
Phase
- Phase 4
- 14
- Phase 2
- 11
- Phase 3
- 7
- Phase 1
- 6
- Early Phase 1
- 1
Where
- United States
- 25
- Denmark
- 3
- Italy
- 3
- United Kingdom
- 3
- Brazil
- 2
- Turkey (Türkiye)
- 2
Who runs them
University of Miami (3) · Lipocine Inc. (3) · GlaxoSmithKline (2) · Seattle Institute for Biomedical and Clinical Research (2) · Marius Pharmaceuticals (2) · Halozyme Therapeutics (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · University of Florida (1)
Studies
Recruiting first, then most recently updated. Showing 50 of 53 — search for more.
- Anthropometric, Functional and Lifestyle Factors Associated With Testosterone Levels in Middle-Aged MenRecruitingNCT074762221 country
- AIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary HypogonadismEnrolling by invitationNCT07761546Not applicable1 country
- Anticipated Stigma, Illness Identity, and Quality of Life in Male HypogonadismNot yet recruitingNCT077525111 country
- Pain Alleviation With Testosterone in Opioid-Induced HypogonadismRecruitingNCT04798469Phase 21 country
- Late Subclinical Cardiovascular Disease in Testicular Cancer SurvivorsRecruitingNCT056113071 country
- Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active SurveillanceNot yet recruitingNCT07278362Phase 41 country
- Testosterone Replacement in Male Cancer Survivors With Fatigue and Low TestosteroneRecruitingNCT04049331Phase 21 country
- Testosterone Treatment in Men With Chronic Kidney DiseaseRecruitingNCT05249634Phase 21 country
- Clinical Evaluation of Subcutaneous Testosterone Implants in Men With Symptomatic HypogonadismNot yet recruitingNCT07500766Phase 2
- 52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With HypogonadismRecruitingNCT06689085Phase 31 country
- EndoPAT Device for Endothelial Dysfunction in EDRecruitingNCT06720597Not applicable1 country
- Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal MenNot yet recruitingNCT07328542Phase 41 country
- Fertility Enhancement Through Regenerative Treatment in Ovaries and TestesRecruitingNCT068413281 country
- ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung CancerRecruitingNCT065321491 country
- Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17Not yet recruitingNCT06312761Phase 1/2
- Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and HypogonadismRecruitingNCT03851627Phase 41 country
- Physical Exercise as a Sustainability Tool in Men With Dysmetabolic HypogonadismRecruitingNCT06094036Not applicable1 country
- Study to Compare DITEST to Testosterone Undecanoate in Adult Men With HypogonadismCompletedNCT02966652Phase 11 country
- Testosterone in Bariatric PatientsCompletedNCT03721497Phase 41 country
- Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen DeficiencyActive, not recruitingNCT04301765Phase 21 country
- TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney TransplantationActive, not recruitingNCT07287800Phase 1/21 country
- Natesto Spermatogenesis RebootCompletedNCT05381831Phase 41 country
- A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With HypogonadismCompletedNCT04456296Phase 41 country
- Salivary Testosterone in Men: Diurnal Variation and Post-Prandial ResponsesCompletedNCT043266731 country
- Calciotropic Effects After HCG Stimulation TestCompletedNCT032546411 country
- Vogelxo(R) ABPM Study in Hypogandal MenCompletedNCT04558567Phase 41 country
- Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal MenCompletedNCT04467697Phase 31 country
- The Effects of Natesto For Treatment Of HypogonadismWithdrawnNCT04717362Early Phase 1
- A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS TrialTerminatedNCT05205837Phase 41 country
- A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone InjectionsCompletedNCT04439799Phase 41 country
- Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal MenCompletedNCT03198728Phase 31 country
- Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic MenCompletedNCT05806723Phase 41 country
- Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in MenStatus unknownNCT057731831 country
- Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin TherapyCompletedNCT051103911 country
- Perioperative Testosterone Replacement Therapy in Sarcopenic Male Colorectal Cancer PatientsStatus unknownNCT053672841 country
- Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen ParametersCompletedNCT03203681Phase 41 country
- Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging MaleCompletedNCT03282682Not applicable1 country
- The Impact of Sinopharm COVID-19 Vaccination on Male FertilityStatus unknownNCT049465651 country
- Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal MenCompletedNCT03868059Phase 31 country
- Clomid in Men With Low Testosterone With and Without Prior TreatmentCompletedNCT01904734Phase 21 country
- Gonadal Function in Young to Middle Aged HIV-infected MenCompletedNCT037470031 country
- Periodontal Profile of Hypogonadic MenWithdrawnNCT03176537Phase 41 country
- Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile FunctionCompletedNCT03933618Phase 2
- Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).CompletedNCT03242590Phase 3
- Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021)CompletedNCT03242408Phase 3
- Subcutaneous vs. Intramuscular TestosteroneCompletedNCT03091348Phase 41 country
- Assessment of Blood From Men Receiving Oral TU in Various Collection TubesCompletedNCT03973840Phase 11 country
- A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal MalesTerminatedNCT03335254Phase 1/21 country
- Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2)CompletedNCT03792321Phase 4
- Safety and Efficacy of Intranasal TBS-1 Treatment of Male HypogonadismCompletedNCT01446042Phase 31 country